Skip to content

CELZ

Creative Medical Technology Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.11
+4.72%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue3.0K6.0K11.0K9.0K88.6K
Cost of Revenue55.0K2.2K4.4K3.6K28.5K
Gross Profit(52.0K)3.8K6.6K5.4K60.1K
Operating Expenses
R&D Expense2.0M2.3M2.4M2.0M6.3M
SG&A Expense4.1M3.8M3.2M3.6M3.9M
General & Admin Expense
Selling & Marketing Expense
Other Expenses59.8K123.3K110.5K94.6K92.1K
Total Operating Expenses6.2M6.1M5.8M5.6M10.3M
Cost and Expenses6.2M6.1M5.8M5.6M10.3M
Operating Income (EBIT)(6.2M)(6.1M)(5.7M)(5.6M)(10.2M)
Non-Operating
Interest Income201.6K147.8K250.4K333.6K100.3K
Interest Expense
Net Interest Income201.6K147.8K250.4K333.6K100.3K
Other Non-Op Income/Expense201.6K147.8K250.4K333.6K100.3K
Non-Operating Income (excl Interest)(37.1K)(250.4K)(333.6K)(100.3K)
EBT (Pre-Tax Income)(6.0M)(6.0M)(5.5M)(5.3M)(10.1M)
Income Tax Expense
Bottom Line
Net Income(6.0M)(6.0M)(5.5M)(5.3M)(10.1M)
Earnings from Cont. Ops(6.0M)(6.0M)(5.5M)(5.3M)(10.1M)
Earnings from Discont. Ops
Bottom Line Net Income(6.0M)(6.0M)(5.5M)(5.3M)(10.1M)
Per Share
Basic EPS($2.00)($2.52)($3.71)($3.76)($9.28)
Diluted EPS($2.00)($2.52)($3.71)($3.76)($9.28)
Revenue Per Share$0.00$0.00$0.01$0.01$0.08
Shares
Basic Shares Outstanding3.7M2.4M1.5M1.4M1.1M
Diluted Shares Outstanding3.7M2.4M1.5M1.4M1.1M
Profitability Metrics
EBITDA(6.1M)(6.0M)(5.4M)(5.2M)(10.1M)
D&A113.8K123.3K110.5K94.6K92.1K
EBIT(6.2M)(6.1M)(5.5M)(5.3M)(10.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026